Freya Biosciences
6 known investors
Freya Biosciences develops innovative therapies targeting immune-mediated diseases that affect women. The company is led by a team with extensive experience in bringing therapeutic drugs to market from major pharmaceutical companies.
Founders & leadership
CA
Colleen Acosta, PhDCEO, Co-Founder
JV
Johan van Hylckama Vlieg, PhDCSO, Co-Founder
Investors · 6
Angelini VenturesRome
Indaco Venture PartnersMilan
OMX VenturesLincolnshire
Sofinnova PartnersParis · $540K – $27M
Bill & Melinda Gates Foundationreported · 2 sourcesSeattle
Also in the syndicate · 1
EIFO
Funding
SEC filings, press & company announcements$38M disclosed across 1 of 2 rounds · 2023–2024
- Undisclosed amountSeries ANov 2024
Bill & Melinda Gates Foundation, EIFO
Source ↗ - $38MSeries ADec 2023 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Freya Biosciences do?
- Freya Biosciences develops innovative therapies targeting immune-mediated diseases that affect women. The company is led by a team with extensive experience in bringing therapeutic drugs to market from major pharmaceutical companies.
- Who founded Freya Biosciences?
- Freya Biosciences was founded by Colleen Acosta, PhD, Johan van Hylckama Vlieg, PhD.
- Who are Freya Biosciences's investors?
- Freya Biosciences's investors include Angelini Ventures, Indaco Venture Partners, OMX Ventures, Sofinnova Partners, Bill & Melinda Gates Foundation.
- How much funding has Freya Biosciences raised?
- Freya Biosciences has disclosed $38M raised across 1 of its 2 known rounds.